Industry2h ago
Isomorphic Labs Raises $2.1 Billion For Drug Discovery
A $2.1 billion funding round fuels Isomorphic Labs as it scales its drug design engine. The Google DeepMind spin-off partnered with Novartis and Eli Lilly to identify hidden drug targets. This approach leverages protein structure prediction to shorten early discovery phases. Practitioners can expect more AI-designed candidates entering clinical trials soon.